IL6 and type 2 diabetes mellitus: Studies [55] have shown that CRP, IL-6, and other cytokines mediate insulin metabolic pathways, weaken insulin receptor signal transduction, induce disorders of glucose metabolism, and stimulate type 2 diabetes.